Holen Sie sich die Stockscreener-App
27.48
3.55%
0.851
Biodesix Inc Aktie (BDSX) Neueste Nachrichten
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
BlackRock Inc. Invests $970,000 in Biodesix, Inc. $BDSX - MarketBeat
Biodesix Stock Price Forecast. Should You Buy BDSX? - StockInvest.us
Biodesix to Participate in Upcoming Investor Conferences - Moomoo
Biodesix Inc (NASDAQ: BDSX) Stock Price, News & Analysis - kalkine.ca
BioDesix (NASDAQ:BDSX) Passes Minervini Trend Template but Setup Quality Remains Weak - ChartMill
What Makes Biodesix, Inc. (BDSX) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Wall Street Analysts See a 26.72% Upside in Biodesix (BDSX): Can the Stock Really Move This High? - Yahoo Finance
Biodesix Inc (BDSX) Stock Up 9.0% but GF Value Says Overvalued -- GF Score: 51/100 - GuruFocus
Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect? - qz.com
PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now? - The Globe and Mail
Biodesix (BDSX) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison on the Day; After Earnings: The Stock Loses 5.91% in the Latest SessionCEO Earnings Statement - vinanet.vn
Biodesix (BDSX) Results Check: The Bottom-Line Figure Beats Its Comparison; After Earnings: The Market Price Declines 3.91% in Latest TradingGuidance Accuracy Score - Vinanet
46,989 Shares in Biodesix, Inc. $BDSX Purchased by GSA Capital Partners LLP - MarketBeat
AIGH Capital Management LLC Acquires New Stake in Biodesix, Inc. $BDSX - MarketBeat
Biodesix (BDSX) Edges Higher at $24.0 as Bulls Defend Key SupportVol Target Rebalance - vinanet.vn
Walleye Capital LLC Makes New $1.68 Million Investment in Biodesix, Inc. $BDSX - MarketBeat
Sei Investments Co. Makes New Investment in Biodesix, Inc. $BDSX - MarketBeat
BDSX Q2 2026 Earnings: EPS Beats Estimates by 22.85% as Loss NarrowsEarnings Preview - vinanet.vn
BDSX | Biodesix, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Biodesix director Jack Schuler buys company stock, valued at $366,991 By Investing.com - Investing.com Australia
Biodesix director Jack Schuler buys company stock, valued at $366,991 - Investing.com
BDSX Q2 2026 Earnings: Narrower Loss Beats Estimates as Shares Dip 1.78Earnings Yield Spread - Vinanet
Biodesix (NASDAQ:BDSX) Director Jack Schuler Buys 15,000 Shares of Stock - MarketBeat
Biodesix Insider Bought Shares Worth $366,992, According to a Recent SEC Filing - marketscreener.com
Biodesix Inc (BDSX) major holder Jack W. Schuler buys 15,000 shares - Stock Titan
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Biodesix director Jack Schuler buys $665,940 in company stock By Investing.com - Investing.com Australia
Biodesix (NASDAQ:BDSX) Director Jack Schuler Purchases 13,700 Shares of Stock - MarketBeat
Insider Buying: Biodesix (NASDAQ:BDSX) Director Purchases 13,900 Shares - MarketBeat
Biodesix director Jack Schuler buys $665,940 in company stock - Investing.com India
Biodesix at Canaccord Genuity conference: growth, margins in focus By Investing.com - Investing.com Nigeria
Biodesix (BDSX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Biodesix (BDSX) major holder Jack W. Schuler adds shares via trusts - Stock Titan
Biodesix Sees Nodify Growth, Reaffirms Revenue Outlook at Canaccord Conference - TradingView
Biodesix, Inc. (BDSX) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Canaccord raises Biodesix stock price target on strong test volume By Investing.com - Investing.com India
Wall Street Analysts Think Biodesix (BDSX) Could Surge 31.91%: Read This Before Placing a Bet - Yahoo Finance
BDSX Maintained by Canaccord Genuity -- Price Target Raised to $35 - GuruFocus
Canaccord Genuity Group Issues Positive Forecast for Biodesix (NASDAQ:BDSX) Stock Price - MarketBeat
Canaccord raises Biodesix stock price target on strong test volume - Investing.com India
HC Wainwright Forecasts Biodesix's Q3 Earnings (NASDAQ:BDSX) - MarketBeat
Earnings Update: Here's Why Analysts Just Lifted Their Biodesix, Inc. (NASDAQ:BDSX) Price Target To US$32.67 - webull.com
H.C. Wainwright Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $27 - Moomoo
Biodesix Inc (BDSX) Stock News Today - TradingKey
Biodesix boosts sales, trims loss as diagnostics firm pushes toward profitability - BizWest
A Quick Look at Today's Ratings for Biodesix(BDSX.US), With a Forecast Between $27 to $40 - Moomoo
Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX) - The Globe and Mail
BDSX Maintains Buy Rating -- Price Target Raised to $27.00 by HC Wainwright - GuruFocus
Biodesix, Inc. Stock 12‑Month Price Target Raised to $32.67, Implies 43% Upside - TradingView
Biodesix, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
William Blair Initiates Biodesix(BDSX.US) With Buy Rating - Moomoo
Biodesix Announces Second Quarter 2026 Results and Highlights - The Manila Times
Earnings call transcript: Biodesix tops revenue forecast in Q2 2026, shares fall after hours - Investing.com Nigeria
1.84%
1.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):